🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are LIVE in Chicago! Join us on healthbook for coverage from the 2025 ASCO Annual Meeting, bringing you insightful video interviews and informative study highlights from the congress. ➡️ Click here to access the healthbook CHICAGO 2025 Newsroom: healthbook.org/oncology-hemat…

We spoke with Dr David Andorsky about the phase II ASC2ESCALATE study which assessed the effectiveness of a protein kinase inhibitor in patients with chronic-phase chronic myeloid leukemia (CML-CP) after 1 tyrosine kinase inhibitor. Watch the full video on the healthbook CHICAGO

💫 We spoke with Prof. Dr Nicolas Girard about the phase II NIVOTHYM study which assessed the efficacy and safety of a combination treatment for type B3 thymoma and thymic carcinoma. Watch the full video on the healthbook CHICAGO Newsroom here: healthbook.org/oncology-hemat…

👨‍⚕️ We spoke with Prof. Dr Michael Wang about the SYMPATICO trial assessing a new treatment option for mantle cell lymphoma Watch the full video on the healthbook CHICAGO Newsroom here: healthbook.org/oncology-hemat… #healthbook #chicago #oncology #hematology #lymphoma

👨‍⚕️ We had the pleasure to speak with Dr Tian Zhang about the step 1 analysis results from the PDIGREE trial. Watch the full video on the healthbook CHICAGO Newsroom here: healthbook.org/oncology-hemat… #healthbook #chicago #oncology #hematology #genitourinary #cancerresearch

👨‍⚕️ We had the pleasure to speak with Prof. Dr Michele Reni about the CASSANDRA trial which evaluated pre-operative chemotherapy for patients with pancreatic ductal adenocarcinoma at ASCO 2025. Watch the full video on the healthbook CHICAGO Newsroom here: healthbook.org/oncology-hemat…

👨‍⚕️ We spoke with Prof. Dr Constantine Tam about the 5-year follow-up data from the SEQUOIA trial evaluating treatment options for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma at ASCO 2025. Watch the full video on the healthbook CHICAGO Newsroom here:

👨‍⚕️ We spoke with Prof. Dr Vitaly Margulis about the interim results of the phase III ENLIGHTED study investigating a new treatment option for patients with low-grade upper tract urothelial cancer at ASCO25. Watch the full video on the healthbook CHICAGO Newsroom here:

👨‍⚕️ Dr Ellen Heitlinger had the pleasure of speaking with Prof. Dr Andrew Armstrong at ASCO25 about the 5-year overall survival analysis of the ARCHES trial which evaluated a drug plus androgen deprivation therapy regimen in patients with metastatic hormone-senstive prostate

👨‍⚕️ Dr Ellen Heitlinger had the pleasure of speaking with Dr Bastiaan Privé at ASCO25 about the BULLSEYE study which addressed a radioligand therapy option in oligo-metastatic hormone-sensitive prostate cancer. Watch the full video on the healthbook CHICAGO Newsroom here:

👨‍⚕️ Dr Ellen Heitlinger had the pleasure of speaking with Prof. Dr Danny Rischin at ASCO25 about the phase III C-POST trial which evaluated a monoclonal antibody immunotherapy drug for patients with high-risk cutaneous squamous cell carcinoma. Watch the full video on the

👨‍⚕️ Dr Ellen Heitlinger spoke with Prof. Dr John Strickler at ASCO25 about the CodeBreak101 trial assessing a treatment option for previously treated patients with KRAS G12C-mutated metastatic colorectal cancer Watch the full video on the healthbook CHICAGO Newsroom here:

We spoke with Prof. Dr Frank Sinicrope at ASCO25 about the results from the ATOMIC trial which assessed an adjuvant monoclonal antibody immunotherapy option for patients with DNA mismatch repair colon cancer. Watch the full video on the healthbook CHICAGO Newsroom here:

We spoke with Prof. Dr Jean Bourhis at the 2025 ASCO Annual Meeting about the results from the NIVOPOSTOP trial which assessed the addition of adjuvant treatment to chemotherapy for patients with resected head and neck squamous cell carcinoma. Watch the full video on the

We discussed the DESTINY-Breast09 and ASCENT-04 breast cancer studies with Dr Sara Tolaney at the 2025 ASCO Annual Meeting. Watch the full videos on the healthbook CHICAGO Newsroom here: healthbook.org/oncology-hemat… #healthbook #chicago #oncology #breastcancer #cancerresearch

We had the pleasure to discuss the AMPLITUDE study, a phase III trial investigating a drug combination for metastatic castration-sensitive prostate cancer patients, with Prof. Dr Gerhardt Attard at the 2025 ASCO Annual Meeting. Watch the full video on the healthbook CHICAGO

👨‍⚕️ Dr Ellen Heitlinger spoke with Prof. Dr Matthew Matasar at EHA2025 about the POLARGO trial assessing a triplet therapy for the treatment of DLBCL. Watch the full video on the healthbook EHA Newsroom here: healthbook.org/oncology-hemat… #healthbook #EHA #hematology #lymphoma

👨‍⚕️ Dr Ellen Heitlinger spoke with Prof. Dr Steffen Koschmieder at EHA2025 about the LeukemiaNet study. Watch the full video on the healthbook EHA Newsroom here: healthbook.org/oncology-hemat… #healthbook #EHA #hematology #leukemia #cancerresearch

👨‍⚕️ Dr Ellen Heitlinger spoke with Prof. Dr Martin Dreyling at EHA2025 about his highlights from the conference. Watch the full video on the healthbook EHA Newsroom here: healthbook.org/oncology-hemat… #healthbook #EHA #hematology #lymphoma #cancerresearch

👨‍⚕️ We spoke with Dr. Lisa Leypoldt at EHA2025 about the GMMG-CONCEPT trial which evaluated a treatment option for patients with relapsed/refractory multiple myeloma. Watch the full video on the healthbook EHA Newsroom here: healthbook.org/oncology-hemat… #healthbook #EHA #hematology